C4 Therapeutics (CCCC) Other Operating Expenses (2025)

C4 Therapeutics' Other Operating Expenses history runs 2 years deep, the most recent figure standing at $10.7 million for Q3 2025.

• In Q3 2025, Other Operating Expenses changed N/A year-over-year to $10.7 million; the TTM figure through Mar 2026 stood at $10.7 million (changed N/A YoY), while the FY2025 annual figure was $10.7 million, changed N/A from the prior year.
• Other Operating Expenses for Q3 2025 stood at $10.7 million, up from $2.4 million in the prior quarter.
• The five-year high for Other Operating Expenses was $10.7 million in Q3 2025, with the low at $2.4 million in Q1 2024.